About Daiichi Sankyo Group Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose "to contribute to the enrichment of quality of life around the world." In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs
4.1.2 Smart nanocarriers for acidic microenvironments The acidic environment of tumor cells, resulting from aberrant metabolism, influences their behavior and the effectiveness of chemotherapy
In addition, in OA chondrocytes, the decrease in the activity of respiratory chain complexes I, II and III may affect several pathways related to cartilage degradation, including oxidative stress, biosynthesis of chondrocytes, increased inflammation and matrix catabolism induced by cytokines, calcification of cartilage matrix and increased apoptosis of cartilage cells (Blanco et al., 2011)
Designed specifically for athletes who want professional help to achieve their fitness goals
Presented for research literature review only Oguchi M et al
De verscheidenheid aan beschikbare formaten betekent dat je de optie kunt kiezen die het beste bij jouw levensstijl past, of dat nu tabletten zijn die je onderweg kunt innemen, capsules voor precieze dosering, of poeder dat je aan je favoriete shake kunt toevoegen